Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | -32.78% | -47.84% | -66.48% |
May. 27 | Finch Therapeutics Group, Inc.(OTCPK:FNCH) dropped from NASDAQ Composite Index | CI |
May. 10 | Finch Therapeutics Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 1
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biological Drugs
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -87.57% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -87.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Matthew Blischak
CEO | Chief Executive Officer | - | 23-05-15 |
Lance Thibault
DFI | Director of Finance/CFO | 58 | 23-05-15 |
Sonia Timberlake
CTO | Chief Tech/Sci/R&D Officer | - | - |
Matthew Nelson
PRN | Corporate Officer/Principal | - | 21-06-30 |
Michelle L. Rose
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Graf
CHM | Chairman | 52 | 21-04-22 |
Jeffery Smisek
BRD | Director/Board Member | 69 | 17-08-31 |
Chris Shumway
BRD | Director/Board Member | 58 | 20-08-31 |
Domenic Ferrante
BRD | Director/Board Member | 58 | 19-09-24 |
Christian Lange
BRD | Director/Board Member | 44 | 17-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,605,763 | 746,985 ( 46.52 %) | 0 | 46.52 % |
Company contact information
Finch Therapeutics Group, Inc.
75 State Street Suite 100
02109, Boston
+
http://www.finchtherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-66.48% | 2.89M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- FNCH Stock
- Company Finch Therapeutics Group, Inc.